With the aim of pioneering a safe,
effective gene therapy approach, St. Jude scientists have spent years developing an innovative vector for X-linked SCID.
Not exact matches
As the central nervous system is also a target of AAV vectors, Hélène Puccio and Patrick Aubourg's teams are investigating whether a similar
approach using
gene therapy could be as
effective for the spinal cord and cerebellum as it is for the heart.
«Because this mutation already exists in nature and is benign, this «organic
gene therapy»
approach should be
effective and safe to use to treat, and possibly cure, serious blood disorders.
This
approach for
gene therapy to treat fatty liver disease, for example, might prove both safer and more
effective than reengineering cells in the liver itself.
While
effective, the downside to these
approaches to vision rescue is that each disease requires its own form of
gene therapy to correct the particular genetic mutation involved, a time consuming and complex process.